This Post Was Syndicated Under License Via QuoteMedia
Globally Acclaimed Pediatrics Nutrition and Allergies Experts Join Else’s Advisory Board
/* Style Definitions */
Prof. Hania Szajewska will lead the Company’s clinical studies in
will lead key studies in the U.S.
April 12, 2021
ELSE NUTRITION HOLDINGS INC.
the Plant-Based baby, toddler and children nutrition
, is pleased to announce the addition of 2 world-class experts to its Scientific Advisory Board.
“The importance of these 2 new Advisory Board members cannot be understated. Prof. Szajewska and Dr. Venter bring immense and invaluable expertise which significantly bolsters our pathway toward commercializing clean label, plant-based infant nutrition in both the U.S. and European markets,” said
, Else CEO & Co-Founder.
, MD, is Professor and Chair of the Department of Pediatrics at the Medical University of
, she served as the Editor-in-Chief of the
Journal of Pediatric Gastroenterology and Nutrition
. Previously, Prof. Szajewska served as a member of the Council and then as the General Secretary of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). She also served as the Secretary of the ESPGHAN Committee on Nutrition. Most recently (
), she joined the Board of Directors of the International Scientific Association for Probiotics and Prebiotics. She has co-authored more than 320 publications. In 2020, Prof. Szajewska has been ranked as one of the world’s top 2% most-cited researchers. She will lead Else’s clinical studies in
obtained her PhD from the University of Southampton. She moved from the UK in 2015 where she had been performing research into food allergies and allergy prevention as a Senior Lecturer at the University of
at the David Hide Centre on the Isle of Wight. Dr. Venter (PhD RD) is currently an Associate Professor of Pediatrics, Section of Allergy/Immunology at the Children’s Hospital Colorado and
University of Colorado Denver
, where she is conducting research in allergy prevention and working with children with food allergies. She is a member of American, European, and British Allergy Societies. She is a member of European and American food allergy guidelines on Allergy Prevention. She was also a member of the NICE (UK) and National Institutes for Allergy and Infectious Diseases Food Allergy guidelines. She will lead Else’s hypoallergenicity studies in the U.S.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an
-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in
. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at
Harvard Medical School
Tel Aviv University
, Schneider Children’s Medical Center of
, Rambam Medical Center and Technion,
and University Hospital
For more information, visit:
or @elsenutrition on Facebook and Instagram.
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia:
SOURCE Else Nutrition Holdings Inc.
View original content to download multimedia: